ClinVar Miner

Submissions for variant NM_000038.6(APC):c.4850_4855del (p.Leu1617_Leu1618del)

dbSNP: rs1057517588
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000411775 SCV000489113 uncertain significance Familial adenomatous polyposis 1 2016-08-25 criteria provided, single submitter clinical testing
Invitae RCV000411775 SCV000552591 uncertain significance Familial adenomatous polyposis 1 2023-11-10 criteria provided, single submitter clinical testing This variant, c.4850_4855del, results in the deletion of 2 amino acid(s) of the APC protein (p.Leu1617_Leu1618del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with APC-related conditions. ClinVar contains an entry for this variant (Variation ID: 371929). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV000574697 SCV000672611 uncertain significance Hereditary cancer-predisposing syndrome 2022-05-06 criteria provided, single submitter clinical testing The c.4850_4855delTTCTAC variant (also known as p.L1617_L1618del) is located in coding exon 15 of the APC gene. This variant results from an in-frame TTCTAC deletion at nucleotide positions 4850 to 4855. This results in the in-frame deletion of two leucine residues between codons 1617 and 1618. This amino acid region is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Color Diagnostics, LLC DBA Color Health RCV000574697 SCV000681689 uncertain significance Hereditary cancer-predisposing syndrome 2019-03-02 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV002230226 SCV004018452 uncertain significance Familial adenomatous polyposis 1 2023-02-14 criteria provided, single submitter clinical testing This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.